The workshop featured an opening from the Director of the GATE Institute, prof. Sylvia Ilieva, and talks from prominent researchers in the field of Digital Health and related areas.

Dean Palejev, PhD, who leads the Digital Health application domain at the GATE Institute and is also an Associate Professor at the Institute of Mathematics and Informatics at the Bulgarian Academy of Sciences, presented GATE’s flagship project on Alzheimer’s disease.

Dr Ivan Koychev –  a neuropsychiatrist at the Oxford University Hospitals NHS Foundation Trust and a Senior Clinical Researcher at the University of Oxford introduced the Dementias Platform UK.

Dr Dimitar Jetchev, the CTO and a co-founder of Inpher Inc., (a US-Swiss based start-up developing a platform for privacy-preserving data analytics) and a Professor of Mathematics at EPFL, Switzerland presented privacy-preserving AI-based diagnostic tools for Alzheimer’s disease.

Vassil Vassilev, PhD, Head of the Cyber Security Research Centre of London Metropolitan University, UK and a leading researcher at GATE Institute spoke about the GATE Data platform.

The moderator was Prof. Graham Kemp, Chalmers University of Technology, Sweden.

The Director of the GATE Institute, Prof. Sylvia Ilieva, participated also in the main programme of the Biotech Atelier earlier on 1st October 2021, and in particular in the session “Digital Health: Supporting Health Through Technologies”. In her presentation, she focused on AI and data technologies as key enablers of the healthcare digital transformation and underlined the huge potential for health data sharing and utilization. Prof. Ilieva outlined three main principles for the successful adoption of AI in healthcare – data and security, analytics and insights, and shared experience. “We need to convince people that data sharing in healthcare is for the benefit of the society.”, concluded prof. Ilieva.